Literature DB >> 1912831

Treating bony metastases.

D Dodwell, A Howell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1912831      PMCID： PMC1670599          DOI： 10.1136/bmj.303.6800.429

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

1.  Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.

Authors:  A R Morton; J A Cantrill; G V Pillai; A McMahon; D C Anderson; A Howell
Journal:  BMJ       Date:  1988-09-24

2.  Diphosphonates for osteolytic metastases.

Authors:  I Elomaa; C Blomqvist; L Porkka; T Holmström; T Taube; C Lamberg-Allardt; G H Borgström
Journal:  Lancet       Date:  1985-05-18       Impact factor: 79.321

3.  Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy.

Authors:  A R Morton; J A Cantrill; A E Craig; A Howell; M Davies; D C Anderson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

4.  Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trial.

Authors:  C Blomqvist; I Elomaa; L Porkka; S L Karonen; C Lamberg-Allardt
Journal:  Bone       Date:  1988       Impact factor: 4.398

5.  Treatment of metastatic bone pain with strontium-89.

Authors:  R G Robinson; J A Spicer; D F Preston; A V Wegst; N L Martin
Journal:  Int J Rad Appl Instrum B       Date:  1987

6.  Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.

Authors:  S Adami; G Salvagno; G Guarrera; G Bianchi; R Dorizzi; S Rosini; G Mobilio; V Lo Cascio
Journal:  J Urol       Date:  1985-12       Impact factor: 7.450

7.  Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.

Authors:  H I Harinck; O L Bijvoet; H J Blanksma; P J Dahlinghaus-Nienhuys
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

8.  Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.

Authors:  J L Mansi; U Berger; D Easton; T McDonnell; W H Redding; J C Gazet; A McKinna; T J Powles; R C Coombes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

9.  Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study.

Authors:  N W Clarke; I B Holbrook; J McClure; N J George
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

10.  Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  R E Coleman; P J Woll; M Miles; W Scrivener; R D Rubens
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640
View more
  2 in total

1.  Treating bony metastases.

Authors:  C Baughan
Journal:  BMJ       Date:  1991-10-05

Review 2.  Palliative medicine.

Authors:  R J George; A L Jennings
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.